BiotechTube
Home/Cue Biopharma/Colin Sandercock
CS

Colin Sandercock

Senior Vice President and General Counsel

Cue Biopharma

Therapeutic Areas

Autoimmune DiseasesOncology

Cue Biopharma Pipeline

DrugIndicationPhase
CUE-401Autoimmune and Inflammatory DiseasesPreclinical

Leadership Team at Cue Biopharma

LW
Lucinda Warren
Interim President and Chief Executive Officer
DB
Daniel Baker
Interim Chief Development Officer
View full Cue Biopharma profile